Form 4 for QTWO Q2 Holdings, Inc.
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-21 · accession 0001410384-23-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-22 | 2023-12-21 | QTWO | Breeden John E | COO | S - Sale+OE | $42.92 | -25.4K | 188.4K | -12% | -$1.09M |
| D | 2023-12-22 | 2023-12-21 | QTWO | Breeden John E | COO | M - OptEx | $35.80 | +25.4K | 221.2K | +13% | +$909.2K |
| D | 2023-12-22 | 2023-12-21 | QTWO | Breeden John E | COO | M - OptEx | $0.00 | -25.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-21 | S | D | 25,397 | $42.92 | 188,416 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.63 to $43.365 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Reported amount reduced by 7,427 units as comparted to reporting person's prior Form 4 reflecting forfeiture by reporting person of unearned units under the Market Stock Unit Grant dated March 13, 2020, which was originally reported on Form 4 at the time of grant using the total target number of units. Forfeited units represent target units that were not earned due to failure to attain the required performance measure (TSR relative to Russell 2000 Index) on one or more of the performance measure dates as of the end of the final performance period for the grant. |
| 2 | Common | Common Stock | 2023-12-21 | M | A | 25,397 | $35.80 | 221,240 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-12-21 | M | D | 25,397 | $0.00 | 0 | D | $35.80 · 2018-02-21 to 2024-02-21 | 25,397 Common Stock | (F4) This option grant vested as to 1/4 of the total option grant on February 21, 2018, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. |